Companies: 11,062     total market cap: โ‚ฌ130.921 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Novavax
NVAX
#5514
Rank
โ‚ฌ1.28 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
7,80ย โ‚ฌ
Share price
3.74%
Change (1 day)
43.54%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Novavax (NVAX) - Total assets

Total assets on the balance sheet as of March 2026 : โ‚ฌ0.91 Billion

According to Novavax's latest financial reports the company's total assets are โ‚ฌ0.91 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novavax - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31โ‚ฌ1.00 B-33.21%
2024-12-31โ‚ฌ1.49 B-7.78%
2023-12-31โ‚ฌ1.62 B-22.78%
2022-12-31โ‚ฌ2.10 B-7.45%
2021-12-31โ‚ฌ2.27 B76.85%
2020-12-31โ‚ฌ1.28 B733.31%
2019-12-31โ‚ฌ0.15 B-15.07%
2018-12-31โ‚ฌ0.18 B-27.89%
2017-12-31โ‚ฌ0.25 B-32.75%
2016-12-31โ‚ฌ0.37 B6.17%
2015-12-31โ‚ฌ0.35 B55.58%
2014-12-31โ‚ฌ0.22 B33.29%
2013-12-31โ‚ฌ0.17 B120.05%
2012-12-31โ‚ฌ77.37 M50.92%
2011-12-31โ‚ฌ51.26 M-8.89%
2010-12-31โ‚ฌ56.26 M-5.83%
2009-12-31โ‚ฌ59.75 M9.01%
2008-12-31โ‚ฌ54.81 M-12.34%
2007-12-31โ‚ฌ62.52 M-32.31%
2006-12-31โ‚ฌ92.36 M29.67%
2005-12-31โ‚ฌ71.23 M23.89%
2004-12-31โ‚ฌ57.49 M-13.99%
2003-12-31โ‚ฌ66.84 M21.52%
2002-12-31โ‚ฌ55.01 M-27.61%
2001-12-31โ‚ฌ75.99 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novartis
NVS
โ‚ฌ104.07 B 11,262.78%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ182.28 B 19,802.80%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ100.10 B 10,829.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ73.10 B 7,881.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
โ‚ฌ2.79 B 204.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚ฌ0.44 B-50.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ0.20 B-77.58%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚ฌ7.33 M-99.20%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.40 B-55.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ1.28 B 40.06%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com